Researchers found that two doses of a nine-valent HPV vaccine provided similar antibody responses among girls and boys aged 9 to 14 yearsas the standard three doses given to adolescent girls and young women aged 16 to 26 years ( JAMA 2016 Nov 21. [Epub ahead of print]).
NOVEMBER 29, 2016